Family Therapy Supervision in Action

2017 ◽  
Vol 65 (1) ◽  
pp. 111-121
Author(s):  
Paula Ochs ◽  
Jude Webster

There is a growing body of research, as the psychodrama community has understood for some time, that supports the idea that our bodies have their own intelligence and that insight can come from action. By working nonverbally using sculpting and other psychodramatic methods in family therapy supervision, we as family therapy supervisors, have found that clinicians are able to overcome therapeutic impasse with clients when they work through difficulties using insights that come from the body and action. This article describes our method and provides clinical examples of its effectiveness working with couples and families.

Author(s):  
Jeff Chang ◽  
Monica Sesma Vazquez ◽  
Ka Man Cheang ◽  
Shannon McIntosh ◽  
Karl Tomm

2021 ◽  
Vol 18 ◽  
Author(s):  
Rosanna Squitti ◽  
Mariacarla Ventriglia ◽  
Alberto Granzotto ◽  
Stefano L. Sensi ◽  
Mauro Ciro Antonio Rongioletti

: Alzheimer’s disease (AD) is a type of dementia very common in the elderly. A growing body of recent evidence has linked AD pathogenesis to copper (Cu) dysmetabolism in the body. In fact, a subset of patients affected either by AD or by its prodromal form known as Mild Cognitive Impairment (MCI) have been observed to be unable to maintain a proper balance of Cu metabolism and distribution and are characterized by the presence in their serum of increased levels of Cu not bound to ceruloplasmin (non-ceruloplasmin Cu). Since serum non-ceruloplasmin Cu is a biomark- er of Wilson's disease (WD), a well-known condition of Cu-driven toxicosis, in this review, we pro- pose that in close analogy with WD, the assessment of non-ceruloplasmin Cu levels can be exploit- ed as a cost-effective stratification and susceptibility/risk biomarker for the identification of some AD/MCI individuals. The approach can also be used as an eligibility criterion for clinical trials aim- ing at investigating Cu-related interventions against AD/MCI.


1990 ◽  
Vol 1 (3) ◽  
pp. 65-74 ◽  
Author(s):  
Lorraine M. Wright ◽  
Pamela G. Luckhurst ◽  
Jon K Amundson

2009 ◽  
Vol 21 (1) ◽  
pp. 18-38 ◽  
Author(s):  
Marisol Garcia ◽  
Iva Kosutic ◽  
Teresa McDowell ◽  
Stephen A. Anderson

2011 ◽  
Vol 4 (4) ◽  
pp. 147-151 ◽  
Author(s):  
Änne Bartels ◽  
Keelin O'Donoghue

Cholesterol forms part of every cell in the human body, and also helps make and metabolize hormones, bile acids and vitamin D. Human plasma cholesterol levels are determined by production in the liver and by dietary intake. Lipoproteins carry cholesterol around the body, and facilitate it crossing the placenta. Cholesterol is carefully monitored in the non-pregnant adult population, where its association with atherosclerosis and cardiovascular disease is well understood. Although it is known that cholesterol rises in pregnancy, at present it is not routinely measured or treated. The effects of maternal high cholesterol on pregnancy and on fetal development are not yet fully understood. However, a growing body of evidence from animal and human studies suggests adverse consequences of high cholesterol levels in pregnancy.


Sign in / Sign up

Export Citation Format

Share Document